Who to call at NOWDiagnostics, Inc., and when
Fundz watches for the moments NOWDiagnostics, Inc. starts buying, and tells you who to reach.
- An alert the day NOWDiagnostics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NOWDiagnostics, Inc., from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
NOWDiagnostics and Labcorp Collaborate to Expand Access to FDA-Authorized Syphilis Test in the U.S.
Oct 16, 2024
Contract Type
partnership
SpringdaleManufacturingBiotechnologyHealthcareHealth CareMedical DeviceDescription
NOWDiagnostics, Inc. announced a collaboration with Labcorp to distribute its First To Know® Syphilis Test in professional and healthcare settings, aiming to expand access to the test that provides results in 15 minutes with as little as a drop of blood. This partnership is significant in addressing the concerning rise in syphilis cases and aims to support earlier detection and treatment.
Related People
Agreement Insights
What this usually meansStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
NOWDiagnostics, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.